The central government informed Parliament on Friday that Bharat Biotech's Covaxin has been granted Emergency Use Listing (EUL) in 13 countries as on January 31 as per the WHO.
On October 25, Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII) had submitted an application to the DCGI seeking regular market authorization for Covishield.